---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-084047"
form_type: "8-K"
ticker: "LMRI"
cik: "0002071288"
company_name: "Lumexa Imaging Holdings, Inc."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:53:05.580936+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# Lumexa Imaging prelim Q4 rev at least $261M, FY rev at least $1.016B; guides FY 2026 rev $1.045-1.097B

## Summary
- Prelim Q4 2025 rev at least $261M (+5.2% YoY); adj. EBITDA at least $63M (+17% YoY).
- Prelim FY 2025 rev at least $1.016B (+7.1% YoY); adj. EBITDA at least $229M (+14% YoY).
- FY 2026 guidance: rev $1.045-1.097B, adj. EBITDA $234-242M (incl. ~$7M public co. costs).
- Net loss improved: FY 2025 prelim loss not larger than $43.8M vs $94.1M prior year.
- Opened 9 de novo centers in 2025; PET volumes up 17% consolidated; AI pilot in NJ.

## SEC filing metadata
- accession: 0001193125-26-084047
- form_type: 8-K
- ticker: LMRI
- cik: 0002071288
- company_name: Lumexa Imaging Holdings, Inc.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2071288/000119312526084047/0001193125-26-084047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2071288/000119312526084047/d40982d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-084047
- JSON: https://secwatch.observer/filing/0001193125-26-084047.json
- Plain text: https://secwatch.observer/filing/0001193125-26-084047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.